Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care professional healthcare settings.Learn more
Medical devices & IVD
Regenerative therapies & aesthetics
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, aesthetics and assays for testing of human diseases and conditions, particularly for point-of-care professional healthcare settings.Learn more
Delivering Transformative Therapies and Advancing Health Equity
Advancements recognize us for treatments developed for patients with a total of 100 agents launched from 2002 to 2021.Read More
2002
Cellex established
2009-2012
· 2009-The world' s only FDA-approved saliva + blood HIV test kit · 2012-The world' s only two (Abbott) leukemia virus detection kits(To date)
2015
2009-The world' s only FDA-approved saliva + blood HIV test kit2012-The world' s only two (Abbott) leukemia virus detectionkits(To date)
2019
2009-The world' s only FDA-approved saliva + blood HIV test kit2012-The world' s only two (Abbott) leukemia virus detectionkits(To date)
2020
2009-The world' s only FDA-approved saliva + blood HIV test kit2012-The world' s only two (Abbott) leukemia virus detectionkits(To date)
Cellex-Globally Licensed Sold in 90 Countries
80+ countries under FDA licenses, 15 therapeutic indication global markets.
Learn more about how we are innovating
Patients are our inspiration as we continue to pursue the fight against cancer
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care professional healthcare settings.
Explore our stories
influenza | 2026.06.15
influenza diagnostic test based on detection of viral neuraminidase activity
influenza | 2026.06.15
A rapid influenza diagnostic test based on detection of viral neuraminidase activity
A rapid | 2026.06.15
A rapid influenza diagnostic test based on detection of viral neuraminidase activity
Innovation | 2026.06.03
